US 8802844
Isothiazolopyridinones useful for the treatment of (inter alia) cystic fibrosis
granted A61PA61P11/00A61P13/12
Quick answer
US patent 8802844 (Isothiazolopyridinones useful for the treatment of (inter alia) cystic fibrosis) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Aug 12 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61P, A61P11/00, A61P13/12, A61P19/02, A61P19/08